论文部分内容阅读
目的:观察及评价国产头孢克洛分散片治疗肺部感染的临床疗效及不良反应。方法:150例确诊为肺部感染的住院患者接受头孢克洛分散片治疗,口服0.25g,一天3次(较重的感染者口服0.5g,一天3次;3例肾功能不全者口服0.25g,每隔12h服1次),疗程7～14天。结果:肺部感染的总有效率为88.7％,细菌清除率为83.3％,不良反应发生率为3.33％。结论:头孢克洛分散片可作为葡萄球菌属、大肠杆菌及流感嗜血杆菌等所致的肺部感染的良好药物,且服用方便、安全。
Objective: To observe and evaluate the clinical efficacy and adverse reactions of domestic cefaclor dispersible tablets in the treatment of pulmonary infection. Methods: 150 hospitalized patients diagnosed as pulmonary infection were treated with cefaclor dispersible tablets, orally 0.25g, 3 times a day (heavier infected oral 0.5g, 3 times a day; 3 cases of renal insufficiency oral 0.25g , Every 12h service 1), treatment 7 to 14 days. Results: The total effective rate of pulmonary infection was 88.7%, the bacterial clearance rate was 83.3% and the adverse reaction rate was 3.33%. Conclusion: Cefaclor dispersible tablets can be used as a good medicine for lung infections caused by Staphylococcus, Escherichia coli and Haemophilus influenzae, and it is convenient and safe to take.